Friday, June 09, 2017 8:59:54 PM
"this development-stage company develops proprietary technologies that it intends to implement through state-level partners." Hmmmmm
As medical marijuana gains more acceptance, many companies are now participating not only in distributing the product, but also in research and development to improve the production chain. GrowBlox Sciences, Inc is a company that offers solutions for cultivating and processing medical cannabis. Based in Las Vegas, Nevada, this development-stage company develops proprietary technologies that it intends to implement through state-level partners.
A primary technology of GrowBlox Sciences is the GrowBlox Cannabis Grow Chamber. It is an indoor plant-growing chamber with controlled climate and environmental parameters. Another is the InCUBEator Cannabis Propagation Chamber, which is used to ensure consistency in the tissue culture method of cannabis cultivation.
For the extraction of medicinal cannabis compounds, GrowBlox Sciences has ConversionLAB. It uses CO2 to help ensure that the extract is clean. In the final process of drying and curing, the company uses the CureBLOX Cannabis Drying System, which follows a specific algorithm for temperature and humidity. This makes the curing process and the product pathogen-free.
GrowBlox Sciences also presents itself as a leader in processing state and local licenses where there are medical cannabis programs. The company has specialists who cover standard application requests like compliance, security, branding, packaging, and sales plans.
Founded in 2001, GrowBlox Sciences, Inc started out as Flagstick Ventures, Inc. It became the Diabetic Treatment Centers of America, Inc in 2004, then Signature Exploration and Production Corp in 2008. Finally, it changed to GrowBlox Sciences, Inc in April 2014.
The company, valued at USD 22.41 M, currently trades in the OTC markets as GBLX. Its key executives are Craig M. Ellins, CEO and Chairman; Steven W. Weldon, CFO and Chief Accounting Officer; and Dr. Andrea Small-Howard, Chief Science Officer.
http://www.greenrushreview.com/growblox-sciences/
Recent GBLX News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/12/2024 09:39:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 10:07:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/10/2023 02:00:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 08:15:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 06:31:48 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 08/02/2023 08:18:58 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 07/14/2023 08:12:47 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 06/30/2023 12:00:24 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM